Yaqing Zhang, Hongyun Gan, Fei Zhao, Xiaomei Ma, Xiaofeng Xie, Rui Huang, & Jin Zhao. (2021). CPEB4-Promoted Paclitaxel Resistance in Ovarian Cancer In Vitro Relies on Translational Regulation of CSAG2. Frontiers Media S.A..
Chicago Style (17th ed.) CitationYaqing Zhang, Hongyun Gan, Fei Zhao, Xiaomei Ma, Xiaofeng Xie, Rui Huang, and Jin Zhao. CPEB4-Promoted Paclitaxel Resistance in Ovarian Cancer In Vitro Relies on Translational Regulation of CSAG2. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationYaqing Zhang, et al. CPEB4-Promoted Paclitaxel Resistance in Ovarian Cancer In Vitro Relies on Translational Regulation of CSAG2. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.